Our study suggests that EVs from HFpEF patients with CRS are directly injurious to renal epithelial cells in the short term, driving expression of injury markers (LCN2, IL18, HAVCR1) that have previously been shown to be elevated in the urine of patients with CRS (32, 33). This evidence concerns the gene LCN2 and congenital rubella syndrome.